- Home
- KEP vs SNN Comparison
KEP vs SNN Comparison
Compare KEP & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KEP
- SNN
- Stock Information
- Founded
- KEP 1961
- SNN 1856
- Country
- KEP South Korea
- SNN United Kingdom
- Employees
- KEP N/A
- SNN N/A
- Industry
- KEP Electric Utilities: Central
- SNN Industrial Specialties
- Sector
- KEP Utilities
- SNN Health Care
- Exchange
- KEP Nasdaq
- SNN Nasdaq
- Market Cap
- KEP 12.1B
- SNN 12.7B
- IPO Year
- KEP N/A
- SNN 1999
- Fundamental
- Price
- KEP $10.71
- SNN $28.83
- Analyst Decision
- KEP
- SNN Hold
- Analyst Count
- KEP 0
- SNN 3
- Target Price
- KEP N/A
- SNN $27.50
- AVG Volume (30 Days)
- KEP 503.8K
- SNN 780.9K
- Earning Date
- KEP 06-27-2025
- SNN 07-31-2025
- Dividend Yield
- KEP N/A
- SNN 2.58%
- EPS Growth
- KEP 667.18
- SNN 56.15
- EPS
- KEP 5.56
- SNN 0.47
- Revenue
- KEP $64,053,841,898.00
- SNN $5,810,000,000.00
- Revenue This Year
- KEP $5.65
- SNN $6.87
- Revenue Next Year
- KEP $2.21
- SNN $5.19
- P/E Ratio
- KEP $3.81
- SNN $30.62
- Revenue Growth
- KEP 4.91
- SNN 4.70
- 52 Week Low
- KEP $6.68
- SNN $23.69
- 52 Week High
- KEP $11.44
- SNN $31.72
- Technical
- Relative Strength Index (RSI)
- KEP 54.63
- SNN 49.61
- Support Level
- KEP $10.08
- SNN $28.40
- Resistance Level
- KEP $10.84
- SNN $30.38
- Average True Range (ATR)
- KEP 0.20
- SNN 0.36
- MACD
- KEP -0.10
- SNN -0.17
- Stochastic Oscillator
- KEP 45.96
- SNN 30.00
About KEP Korea Electric Power Corporation
Korea Electric Power Corp is an electric utility company in which the government of South Korea holds a controlling stake. The firm operates in the following segments: Transmission and distribution, Electric power generation (Nuclear), Electric power generation (Non-Nuclear), Plant maintenance & engineering service, and Others. The majority of the energy produced by the company comes from its nuclear and coal-fired assets. Korea Electric Power generates revenue through the Transmission and distribution segment. Geographically, it derives maximum revenue from Domestic operations.
About SNN Smith & Nephew SNATS Inc.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.